SLC2A1 and colonic neoplasm: METTL3/LDHA axis-induced glucose metabolism may be a potential therapeutic target for CRC cells to overcome 5-FU resistance (112), which was demonstrated to be associated with overexpression of GLUT1 in colon cancer cells.